Global Acute Myeloid Leukemia Therapeutics market to grow at a CAGR of 19.75 percent over the period 2014-2019 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Global Acute Myeloid Leukemia Therapeutics market to grow at a CAGR of 19.75 percent over the period 2014-2019

Description:

Big Market Research has announced a new Report Package "Global Acute Myeloid Leukemia Therapeutics Market -Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential" Get Complete Details At: Acute myeloid leukemia, also known as acute myelogenous leukemia, is a hematopoietic disorder that starts either in hematopoietic stem cells or lineage-specific progenitor cells. Neoplasms arise from bone marrow, however, it spreads quickly into the blood. In the later stages of the disorder, it spreads to spleen, lymph node, liver, brain, spinal cord and testicles. Clonal expansion of the myeloid blasts and the loss of normal hematopoiesis are the main characteristic of acute myeloid leukemia. Enquire At: – PowerPoint PPT presentation

Number of Views:42

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Acute Myeloid Leukemia Therapeutics market to grow at a CAGR of 19.75 percent over the period 2014-2019


1
Global Acute Myeloid Leukemia Therapeutics Market
2015-2019
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast 2019
Published Date Dec 2014
2
Report Description
About Acute Myeloid Leukemia Acute myeloid
leukemia, also known as acute myelogenous
leukemia, is a hematopoietic disorder that starts
either in hematopoietic stem cells or
lineage-specific progenitor cells. Neoplasms
arise from bone marrow, however, it spreads
quickly into the blood. In the later stages of
the disorder, it spreads to spleen, lymph node,
liver, brain, spinal cord and testicles. Clonal
expansion of the myeloid blasts and the loss of
normal hematopoiesis are the main characteristic
of acute myeloid leukemia. The disease affects
the elderly people with age of 67 years. Fever,
pallor, fatigue and hemorrhages are some of the
clinical symptoms of the disease. Smoking,
exposure to certain chemicals such as benzene,
exposure to radiations, cancer patients, who are
treated with chemotherapy, blood disorder or
genetic mutations are some of the risk factors
for the development of acute myeloid leukemia in
patients. Get Complete Report At
http//www.bigmarketresearch.com/global-acute-myel
oid-leukemia-therapeutics-2015-2019-market The
Global Acute Myeloid Leukemia Therapeutics market
to grow at a CAGR of 19.75 percent over the
period 2014-2019.
3
Report Description
Covered in this Report This report covers the
present scenario and the growth prospects of the
Global Acute Myeloid Leukemia Therapeutics market
for the period 2015-2019. To calculate the market
size, the report considers the revenue generated
from the sales of various generic, off-label and
branded therapies used for treatment. The report
also presents the vendor landscape and a
corresponding detailed analysis of the top
vendors in the Global Acute Myeloid Leukemia
Therapeutics market. In addition, the report
discusses the major drivers that influence the
growth of the market and also outlines the
challenges faced by the vendors and the market at
large, as well as the key trends that are
emerging in the market. Enquire About This
Report At http//www.bigmarketresearch.com/report
-enquiry/169995 Global Acute Myeloid Leukemia
Therapeutics Market 2015-2019, has been prepared
based on an in-depth market analysis with inputs
from industry experts. The report covers the
Americas, the APAC regions and the EMEA regions
it also covers the market landscape and its
growth prospects in the coming years. The report
also includes a discussion of the key vendors
operating in this market.
4
Report Description
Key Regions Americas APAC EMEA
Key Vendors Bristol Myers Squibb Celgene
Johnson Johnson Pfizer Other Prominent
Vendors Abbott Ambit BioSciences Amgen
Astex Pharmaceuticals AstraZeneca Baxter
Healthcare Bayer
5
Report Description
Boehringer Ingelheim Celator
Pharmaceuticals Chroma Therapeutics Chugai
Pharmaceutical CTI Biopharma Cyclacel
Pharmaceuticals Eisai F. Hoffmann-La Roche
Immune Pharmaceuticals Innate Pharma Kanisa
Pharmaceuticals Meda Merck Sharp Dohme
Midas Pharmaceuticals Neovii Biotech Nippon
Shinyaku Novo Nordisk Sanofi Sunesis
Pharmaceuticals Teva Pharmaceutical Tolero
Pharmaceuticals
6
Report Description
Market Driver Unmet Needs in the Market For a
full, detailed list, view our report Market
Challenge Expensive Treatment For a full,
detailed list, view our report Market Trend
Expected Entry of Novel Therapies For a full,
detailed list, view our report Key Questions
Answered in this Report What will the market
size be in 2019 and what will the growth rate
be? What are the key market trends? What is
driving this market? What are the challenges to
market growth? Who are the key vendors in this
market space? What are the market opportunities
and threats faced by the key vendors? What are
the strengths and weaknesses of the key vendors?
7
Table Of Contents
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Product
Profiles 05. Market Research Methodology 06.
Introduction 07. Disease Overview 08. Market
Landscape 09. Market Segmentation by Class of
Drugs 10. Geographical Segmentation 11. Buying
Criteria 12. Market Growth Drivers 13. Drivers
and their Impact 14. Market Challenges 15. Impact
of Drivers and Challenges 16. Market Trends 17.
Trends and their Impact 18. Pipeline
Portfolio Get Complete TOC At http//www.bigmarke
tresearch.com/global-acute-myeloid-leukemia-therap
eutics-2015-2019-market
8
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/global-acute-myel
oid-leukemia-therapeutics-2015-2019-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (855) 711-1555E-MAIL
help_at_bigmarketresearch.com
About PowerShow.com